An observational study in Anterior Cruciate Ligament Reconstruction, Knee Injury and Neuromuscular Control, sponsored by KTO Karatay University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-14.
Sponsored by KTO Karatay University · Observational
The anterior cruciate ligament (ACL) plays a crucial role in maintaining knee stability and enabling dynamic movement. ACL injuries are common, especially among athletes, and reconstruction surgery is frequently performed to restore knee function. Despite rehabilitation, neuromuscular deficits-particularly in muscle activation timing-may persist. This study will aim to evaluate the activation timing of quadriceps and hamstring muscles during a functional task in individuals who have undergone ACL reconstruction.
This study will be conducted as a cross-sectional, quantitative investigation involving male participants who have undergone ACL reconstruction using semitendinosus and gracilis tendon grafts. Electromyographic (EMG) signals will be collected using the Noraxon Ultium EMG system and analyzed with Noraxon MyoResearch XP software. Muscle activation onset timing will be assessed for the vastus medialis oblique (VMO), vastus lateralis (VL), semimembranosus (SM), semitendinosus (ST), and biceps femoris (BF). Participants will perform a standardized single-leg squat task, during which EMG-based activation timing will be recorded. The findings are expected to provide insight into neuromuscular control strategies and inform rehabilitation approaches following ACL reconstruction.
249 studies on the registry are indexed under Knee Injuries; 48 are open to participants now.
This study's enrollment of 30 is below the median of 90 across 79 observational studies indexed under Knee Injuries.
Browse Knee Injuries studies →KTO Karatay University is the lead sponsor of 126 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will consist of male individuals aged 18-45 years who have undergone anterior cruciate ligament (ACL) reconstruction using semitendinosus and gracilis tendon grafts.
Exclusion Criteria:
Electromyographic (EMG) data will be collected using the Noraxon Ultium EMG sensor system (Noraxon USA, Inc., Scottsdale, Arizona; sampling frequency: 4000 Hz per channel; gain: 1000 \[signal-to-noise ratio: 1 μV RMS\]; common mode rejection rate \[CMRR\]: -100 dB; input impedance: \>100 MΩ). Prior to electrode placement, any hair on the skin will be removed, and the skin will be cleansed with an alcohol swab to ensure optimal signal quality. Participants will be instructed to cross their arms over their chest and perform the squat slowly and in a controlled manner while maintaining balance. The knee flexion angle will be standardized at 60°, and this angle will be monitored and adjusted using an inclinometer integrated into the EMG system. A metronome will be used to control the squatting speed. Participants will be instructed to reach the squat position within 3 beats of the metronome, maintain the squat position for 3 beats, and return to the starting position within 3 beats.
Also known as: Single-leg-squat protocol
Electromyography
Muscle Activation Timing (%MVIC)
Time frame: Single session (approximately 15-20 minutes per participant)
Plan to share: No — Individual participant data will not be shared to protect participant privacy and confidentiality.
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
KTO Karatay University